Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Schuster, J. E.
  • Cox, R. G.
  • Hastings, A. K.
  • Boyd, K. L.
  • Wadia, J.
  • Chen, Z.
  • Burton, Dennis
  • Williamson, R. A.
  • Williams, J. V.

publication date

  • January 2015

journal

  • Journal of Infectious Diseases  Journal

subject areas

  • Animals
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Chemoprevention
  • Disease Models, Animal
  • Female
  • Humans
  • Immunotherapy
  • Metapneumovirus
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Neutralization Tests
  • Paramyxoviridae Infections
  • Respiratory Syncytial Virus Infections
  • Respiratory Syncytial Virus, Human
  • Treatment Outcome
scroll to property group menus

Research

keywords

  • DBA/2 mouse
  • human metapneumovirus
  • monoclonal antibody
  • paramyxovirus
  • respiratory syncytial virus
scroll to property group menus

Identity

PubMed Central ID

  • PMC4342691

International Standard Serial Number (ISSN)

  • 0022-1899

Digital Object Identifier (DOI)

  • 10.1093/infdis/jiu307

PubMed ID

  • 24864121
scroll to property group menus

Additional Document Info

start page

  • 216

end page

  • 225

volume

  • 211

issue

  • 2

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support